EHP-101 T13289
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
VCE-004.8 is a specific dual agonist of PPAR_ and CB2 receptor with potent anti-inflammatory activity. VCE-004.8 attenuates adipogenesis and prevents diet-induced obesity.
CAS nr:
1818428-24-8
Purity:
98%
Molecular Weight:
433,58
SMILES:
O=C1C(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(C(NCC3=CC=CC=C3)=C1CCCCC)=O
Formula:
C28H35NO3
Pathway:
GPCR/G Protein,Metabolism,DNA Damage/DNA Repair,Metabolism,Chromatin/Epigenetic
Target:
Cannabinoid Receptor,PPAR,PPAR,HIF/HIF Prolyl-Hydroxylase,HIF/HIF Prolyl-Hydroxylase
